Filana Therapeutics, Inc.
MX ˙ BMV ˙ US14817C1071
SecurityMX:FLNA / Filana Therapeutics, Inc.
InstitutionAdvisor Group Holdings, Inc.
Latest Disclosed Ownership31,241 shares
Latest Disclosed Value $ 52,790
Advisor Group Holdings, Inc. reports 1.62% decrease in ownership of FLNA / Filana Therapeutics, Inc.

On May 15, 2026 - Advisor Group Holdings, Inc. filed a 13F-HR form disclosing ownership of 31,241 shares of Filana Therapeutics, Inc. (MX:FLNA) valued at $52,790 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 31,757 shares of Filana Therapeutics, Inc.. This represents a change in shares of -1.62% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F FILANA THERAPEUTICS COM 14817C107 31,241 -516 -1.62 53 -16.13 0.0000
2026-02-17 2025-12-31 13F CASSAVA SCIENCES COM 14817C107 31,757 -3,007 -8.65 63 -22.50 0.0001
2025-11-14 2025-09-30 13F CASSAVA SCIENCES COM 14817C107 34,764 -2,679 -7.15 80 19.40 0.0001
2025-09-04 2025-06-30 13F/A-1 CASSAVA SCIENCES COM 14817C107 37,443 186 0.50 68 21.82 0.0001
2025-08-13 2025-06-30 13F CASSAVA SCIENCES COM 14817C107 41,967 4,710 99 0.0002
2025-05-12 2025-03-31 13F CASSAVA SCIENCES COM 14817C107 37,257 -4,880 -11.58 56 -44.44 0.0001
2025-06-06 2024-12-31 13F/A-1 CASSAVA SCIENCES COM 14817C107 42,137 -110,883 -72.46 99 -97.80 0.0002
2025-02-07 2024-12-31 13F CASSAVA SCIENCES COM 14817C107 152,283 -737 4,476 0.0114
2024-11-13 2024-09-30 13F CASSAVA SCIENCES COM 14817C107 153,020 66,610 77.09 4,503 322.02 0.0102
2024-08-13 2024-06-30 13F CASSAVA SCIENCES COM 14817C107 86,410 3,876 4.70 1,067 -36.26 0.0025
2024-05-10 2024-03-31 13F CASSAVA SCIENCES COM 14817C107 82,534 -35,710 -30.20 1,674 -37.09 0.0037
2024-02-12 2023-12-31 13F CASSAVA SCIENCES COM 14817C107 118,244 -10,400 -8.08 2,662 24.35 0.0047
2023-11-13 2023-09-30 13F CASSAVA SCIENCES COM 14817C107 128,644 19,522 17.89 2,141 -19.97 0.0032
2023-08-21 2023-06-30 13F/A-1 CASSAVA SCIENCES COM 14817C107 109,122 -9,690 -8.16 2,674 -6.67 0.0048
2023-08-10 2023-06-30 13F CASSAVA SCIENCES COM 14817C107 109,122 -9,690 2,674 0.0007
2023-05-12 2023-03-31 13F CASSAVA SCIENCES COM 14817C107 118,812 23,646 24.85 2,865 1.99 0.0054
2023-02-10 2022-12-31 13F CASSAVA SCIENCES COM 14817C107 95,166 56,659 147.14 2,810 74.58 0.0057
2022-11-14 2022-09-30 13F CASSAVA SCIENCES COM 14817C107 38,507 -10,177 -20.90 1,609 17.62 0.0037
2022-08-10 2022-06-30 13F CASSAVA SCIENCES COM 14817C107 48,684 -11,717 -19.40 1,368 -39.58 0.0030
2022-05-04 2022-03-31 13F CASSAVA SCIENCES COM 14817C107 60,401 17,148 39.65 2,264 19.66 0.0044
2022-02-03 2021-12-31 13F CASSAVA SCIENCES COM 14817C107 43,253 4,965 12.97 1,892 -20.40 0.0036
2021-11-05 2021-09-30 13F CASSAVA SCIENCES COM 14817C107 38,288 16,373 74.71 2,377 26.91 0.0050
2021-08-02 2021-06-30 13F CASSAVA SCIENCES COM 14817C107 21,915 -36,974 -62.79 1,873 -29.24 0.0041
2021-05-13 2021-03-31 13F CASSAVA SCIENCES COM 14817C107 58,889 44,615 312.56 2,647 2,628.87 0.0064
2021-02-10 2020-12-31 13F CASSAVA SCIENCES COM 14817C107 14,274 -5,636 -28.31 97 -57.64 0.0003
2020-11-12 2020-09-30 13F CASSAVA SCIENCES COM 14817C107 19,910 15,157 318.89 229 1,535.71 0.0007
2020-08-14 2020-06-30 13F CASSAVA SCIENCES COM 14817C107 4,753 2,429 104.52 14 55.56 0.0000
2020-05-18 2020-03-31 13F CASSAVA SCIENCES COM 14817C107 2,324 2,324 9 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.